Point of Care Tests in the Management of Very Early Medical Abortion
NCT07417787 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130
Last updated 2026-04-07
Summary
This study will investigate the use of a point of care test in patients who are having an abortion at a gestation of \<6 weeks (known as a very early medical abortion). These patients have pregnancy hormone level checked at Day 0 and Day 7 to see if treatment has worked. The investigators plan to use a point of care test machine to see if it is possible to check pregnancy hormone level earlier than Day 7.
Conditions
- Abortion Early
Interventions
- DIAGNOSTIC_TEST
-
Blood test
Patients will undergo one additional blood test than is usual with standard care, to measure Human Chorionic Gonadotropin (HCG) level which will be analysed on a point of care test machine and in the lab
- OTHER
-
Participant Questionnaire
The investigators will administer participant questionnaires to both staff and patients to understand opinions on the point of care test machine
Sponsors & Collaborators
-
NORDIC pharma (funding)
collaborator UNKNOWN -
NHS Lothian
collaborator OTHER_GOV - collaborator OTHER
-
Karolinska University Hospital
collaborator OTHER -
Göteborg University
collaborator OTHER -
Sahlgrenska University Hospital
collaborator OTHER -
University of Edinburgh
lead OTHER
Principal Investigators
-
Sharon Cameron · NHS Lothian
-
John Reynolds-Wright · University of Edinburgh
Eligibility
- Min Age
- 16 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-23
- Primary Completion
- 2027-02-28
- Completion
- 2028-02-29
Countries
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
Pregnancy Dating Test - The Fall of hPL in Urine Over Time
NCT04217200 ·Status: COMPLETED
-
Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing
NCT06747598 ·Status: COMPLETED
-
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189 ·Status: TERMINATED
-
Semiquantitative Urine Pregnancy Test Results At ≥9 Weeks of Gestation
NCT02640378 ·Status: COMPLETED
-
Evaluation of the Quantra QStat System in Obstetric Patients
NCT05875987 ·Status: COMPLETED
-
Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray
NCT05900076 ·Status: COMPLETED
-
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
NCT06523543 ·Status: RECRUITING
-
Detection of hCG in Early Pregnancy Clinical Samples
NCT06228131 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Management of Pregnancies of Unknown Location (PUL)
NCT03461835 ·Status: COMPLETED ·Phase: NA
-
The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes
NCT03106311 ·Status: COMPLETED ·Phase: NA
-
Hemoglobin Testing in Pregnant Patients
NCT05977686 ·Status: RECRUITING
-
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
NCT03831256 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Feasibility of Remote eCTG Monitoring Home@Hospital in Complicated Pregnancies
NCT06859177 ·Status: RECRUITING ·Phase: NA
-
Early PrEgnancy Complications Testing
NCT04079361 ·Status: RECRUITING ·Phase: NA
-
Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling
NCT05453474 ·Status: COMPLETED ·Phase: NA
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
Study of High Risk Non Invasive Prenatal Test Population
NCT04737070 ·Status: UNKNOWN
-
Risk Factors of Ectopic Pregnancy
NCT00194207 ·Status: COMPLETED
-
Covid-19 Infection in Pregnancy
NCT04869202 ·Status: COMPLETED
-
Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial
NCT02145767 ·Status: COMPLETED ·Phase: PHASE2
-
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT05186779 ·Status: TERMINATED
-
Infection and Adverse Pregnancy Outcome
NCT02673216 ·Status: UNKNOWN
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Electronic Notification of Teratogenic Risks
NCT00766207 ·Status: COMPLETED ·Phase: NA